Chemoinformaics analysis of N-[2-(4-Hydroxyphenyl)ethyl]docosanamide
Molecular Weight | 459.759 | nRot | 23 |
Heavy Atom Molecular Weight | 406.335 | nRig | 7 |
Exact Molecular Weight | 459.408 | nRing | 1 |
Solubility: LogS | -2.832 | nHRing | 0 |
Solubility: LogP | 9.872 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 53 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 88.144 |
nHD | 2 | BPOL | 54.608 |
QED | 0.16 |
Synth | 2.117 |
Natural Product Likeliness | -0.026 |
NR-PPAR-gamma | 0.882 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.005 |
CACO-2 | -5.289 |
MDCK | 0.00000767 |
BBB | 0.012 |
PPB | 0.989086 |
VDSS | 2.321 |
FU | 0.00425581 |
CYP1A2-inh | 0.073 |
CYP1A2-sub | 0.173 |
CYP2c19-inh | 0.353 |
CYP2c19-sub | 0.052 |
CYP2c9-inh | 0.092 |
CYP2c9-sub | 0.982 |
CYP2d6-inh | 0.922 |
CYP2d6-sub | 0.086 |
CYP3a4-inh | 0.46 |
CYP3a4-sub | 0.086 |
CL | 5.074 |
T12 | 0.216 |
hERG | 0.941 |
Ames | 0.016 |
ROA | 0.017 |
SkinSen | 0.969 |
Carcinogencity | 0.026 |
EI | 0.373 |
Respiratory | 0.709 |
NR-Aromatase | 0.142 |
Antiviral | Yes |
Prediction | 0.517196 |